Filing Flows › Comparisons › BBNX vs OSUR
Beta Bionics vs Orasure Technologies: BBNX and OSUR compared
Beta Bionics is the larger company: $35.5M of revenue in its latest quarter (Q3 2026) against $30.6M for Orasure Technologies (Q2 2026). Beta Bionics is growing faster (+30% against -2% a year earlier). Orasure Technologies is more profitable, with an operating margin of 17.8% against -74.9%.
Where the money goes: BBNX and OSUR
Beta Bionics (BBNX) · Q3 2026
Beta Bionics, Q3 2026: revenue $35.5M (+30% year over year), operating margin -74.9%, net loss $24.4M, operating cash flow −$12.3M. The chart follows the revenue to costs, profit and cash.
Orasure Technologies (OSUR) · Q2 2026
Orasure Technologies, Q2 2026: revenue $30.6M (-2% year over year), operating margin 17.8%, net earnings $6.2M, operating cash flow −$9.9M. The chart follows the revenue to costs, profit and cash.
| Beta Bionics (BBNX) | Orasure Technologies (OSUR) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $35.5M | $30.6M |
| Revenue growth, Y/Y | +30% | -2% |
| Gross margin | — | 43.5% |
| Operating margin | -74.9% | 17.8% |
| Net earnings | −$24.4M | $6.2M |
| Net margin | -68.6% | 20.4% |
| Operating cash flow | −$12.3M | −$9.9M |
Where the revenue comes from
Orasure Technologies
- Products and services: $29.7M (97%)
- Other: $915K (3%)
- COVID-19: $1K (0%)
Questions
Which is bigger, Beta Bionics or Orasure Technologies?
Beta Bionics is the larger company: $35.5M of revenue in its latest quarter (Q3 2026) against $30.6M for Orasure Technologies (Q2 2026).
Is Beta Bionics or Orasure Technologies growing faster?
Beta Bionics is growing faster (+30% against -2% a year earlier).
Which is more profitable, Beta Bionics or Orasure Technologies?
Orasure Technologies is more profitable, with an operating margin of 17.8% against -74.9%.
More: Beta Bionics earnings · how Beta Bionics makes money · Orasure Technologies earnings · how Orasure Technologies makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 27, 2026; 10-Q filed Aug 7, 2026). Fiscal quarters can end on different dates. Not investment advice.